This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

13 Drugs Facing FDA Approval Decisions

BOSTON ( TheStreet) -- For FDA drug approval decision junkies, October is your World Cup.

By my count, U.S. regulators will issue approval decisions on 13 different drugs during October, making it the busiest month on the FDA calendar by a large margin. The summer -- when news flow in the biotech sector slows down and investor interest wanes -- is a good time to start thinking about the uptick of biotech catalysts in the fall.

For this June update to my regular FDA regulatory calendar, I've highlighted the 13 drugs (impacting 19 different companies) awaiting approval decisions in October. Stocks are listed in chronological order, starting with the earliest FDA approval decision date.

Read on.

1 of 14

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
ALXA $1.95 1.60%
ALKS $57.13 -1.80%
JAZZ $182.65 -0.19%
JNJ $100.78 0.20%
AAPL $130.25 -1.80%


DOW 18,110.14 +72.17 0.40%
S&P 500 2,114.76 +5.84 0.28%
NASDAQ 5,055.4220 -4.8240 -0.10%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs